期刊文献+

急性冠脉综合征伴高同型半胱氨酸血症患者血清VEGF与MMP-9水平检测及临床意义 被引量:3

Clinical study of VEGF and MMP-9 in acute coronary syndrome patients with hyperhomocysteinemia
下载PDF
导出
摘要 目的通过检测急性冠脉综合征(ACS)伴高同型半胱氨酸血症患者血管内皮生长因子(VEGF)、基质金属蛋白酶(MMP-9)的血清水平值,探讨VEGF、MMP-9在ACS伴高同型半胱氨酸血症中的发病机制和作用。方法实验分为高同型半胱氨酸血症ACS组与非高同型半胱氨酸血症ACS组。采用酶联免疫吸附试验(ELISA)法检测ACS患者血清VEGF、MMP-9水平。结果 MMP-9在高同型半胱氨酸血症ACS组明显高于非高同型半胱氨酸血症ACS组(P<0.05),VEGF在高同型半胱氨酸血症ACS组明显低于非高同型半胱氨酸血症ACS组(P<0.05)。VEGF与同型半胱氨酸、MMP-9呈负相关,差异有统计学意义(P<0.05),MMP-9与同型半胱氨酸呈正相关性。结论高同型半胱氨酸血症可以通过降低ACS患者血管修复功能及MMPs动态平衡加速冠状动脉粥样硬化,参与ACS的病理生理机制。 Objective To investigate the changes of VEGF and MMP-9 in serum of the patients with acute coronary syndrome(ACS) with hyperhomocysteinemia(Hcy),and to observe the role of VEGF and MMP-9 in the pathogenesis of acute coronary syndrome with hyperhomocysteinemia.Methods The patients were divided into two groups:acute coronary syndrome and acute coronary syndrome with hyperhomocysteinemia.Enzyme-linked immunosorbent assay (ELISA) was used to detect the concentration of VEGF and MMP-9 in serum of the patients with vascular dementia.Results Serum level of VEGF in the patients with acute coronary syndrome with hyperhomocysteinemia were significantly lower than that in the control group(P〈0.001).Serum level of MMP-9 in the patients with acute coronary syndrome with hyperhomocysteinemia were significantly higher than that in the control group(P〈0.001).VEGF was negatively correlated with Hcy level in serum (P〈0.05),VEGF and MMP-9 also showed negative correlation (P〈0.05),MMP-9 was correlated with Hcy level in serum.Conclusion Hyperhomocysteinemia can reduce the ability of vascular repair and the dynamic balance of MMPs to accelerate coronary atherosclerosis in ACS.
作者 谢婧 刘增长
出处 《检验医学与临床》 CAS 2010年第13期1309-1310,共2页 Laboratory Medicine and Clinic
关键词 高同型半胱氨酸血症 急性冠脉综合征 基质金属蛋白酶9 血管内皮生长因子 hyperhomocysteinemia acute coronary syndromes matrix metalloproteinase 9 vascular endothelial growth factor
  • 相关文献

参考文献10

二级参考文献69

  • 1刘文卫,廖玉华.白细胞介素-18:一种预测冠心病新的重要标记物[J].临床心血管病杂志,2006,22(2):65-66. 被引量:13
  • 2王清涛,秦晓光.同型半胱氨酸的检测和临床应用[J].中华检验医学杂志,2006,29(3):193-195. 被引量:82
  • 3田彩霞,李艳,夏尊恩,陈元秀.急性冠脉综合征患者血浆炎性标志物及血脂水平分析[J].微循环学杂志,2006,16(2):46-48. 被引量:15
  • 4谢江娇,程翔,廖玉华,王朝晖,余娴,姚瑞,夏春燕,宋优,李娅,陈勇,徐莹莹.兔动脉粥样硬化斑块内IL-18表达的动态变化[J].中国分子心脏病学杂志,2005,5(6):773-776. 被引量:22
  • 5Kruk M, Przyluski J, Kalingczuk L, et al. Cumulative incidence of coronary lesions with vulnerable character/sties in patients with stable angina pectoris: an intravaseular ultrasound and angiographic study [ J]. Int J Cardiol, 2005,102 ( 2 ) : 201 -206.
  • 6Hobeika MJ, Thompson RW, Muhs BE, et al. Matrix metalloproteinases in peripheral vascular disease [ J ]. J Vasc Surg, 2007,45 (4) :849 - 857.
  • 7Jones CB, Sane DC, Herrington DM. Matrix metalloproteinases:a review of their structure and role in acute coronary syndrome[J]. Cardiovase Res, 2003, 59(4) : 812 - 823.
  • 8Loftus IM, Naylor AR, Goodall S. Increased matrix metalloprotcinases-9 activity in unstable carotid plaque. A potential role on acute plaque dlsruption[J]. Stroke, 2003, 31 (1) :40 - 44.
  • 9Kai H, Ikeda H, Yasukawa H, et el. Peripheral levels of matrix metalloproteinases-2 and matrix metalloprotelnases-9 are elevated in patients with acute coronary syndromes[ J]. J Am Coil Cardiol, 1998, 32(2) :368 - 372.
  • 10Fiotti N, Altamura N, Orlando C, et al. Metalloproteinases-2, -9 and TIMP-1 expression in stable and unstable coronary plaques undergoing PCI [ J]. Int J Cardiol,2008,127 (3) :350 - 357.

共引文献52

同被引文献28

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部